Literature DB >> 9566398

Decay of postexercise augmentation in the Lambert-Eaton myasthenic syndrome: effect of cooling.

P Maddison1, J Newsom-Davis, K R Mills.   

Abstract

The effect of local cooling on surface recorded compound muscle action potential (CMAP) amplitude was studied in five patients with the Lambert-Eaton myasthenic syndrome (LEMS). The time course of decay of postexercise augmentation of CMAP amplitude characteristically seen in patients with LEMS was determined. We recorded the CMAP from abductor digiti minimi (ADM) in response to supramaximal stimulation of the ulnar nerve. Thirty consecutive stimuli were delivered at 1 Hz immediately after a 10-second period of maximal voluntary contraction. Skin surface temperature was recorded throughout. Initial testing at approximately 30 degrees C was repeated after cooling the hand and forearm by 6 to 12 degrees C. The effects of blood flow on temperature were counteracted by the application of a sphygmomanometer cuff, inflated above systolic blood pressure. The CMAP amplitude following contraction decayed in an exponential manner both during warm and cold conditions. The mean time constant for decay (1/b) in all patients was increased by approximately 25% after cooling. This prolongation of the period of postexercise augmentation of CMAP amplitude in LEMS after cooling concurs with patient reports of symptomatic improvement in cold weather. The mechanism for this benefit is thought to be due to reduction in the rate of removal of calcium ions from the nerve terminal following stimulation, similar to that seen in animal models of short-term synaptic enhancement.

Entities:  

Mesh:

Year:  1998        PMID: 9566398     DOI: 10.1212/wnl.50.4.1083

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

1.  Lambert-Eaton antibodies inhibit Ca2+ currents but paradoxically increase exocytosis during stimulus trains in bovine adrenal chromaffin cells.

Authors:  K L Engisch; M M Rich; N Cook; M C Nowycky
Journal:  J Neurosci       Date:  1999-05-01       Impact factor: 6.167

2.  Electrophysiologic features of SYT2 mutations causing a treatable neuromuscular syndrome.

Authors:  Roger G Whittaker; David N Herrmann; Boglarka Bansagi; Bashar Awwad Shiekh Hasan; Robert Muni Lofra; Eric L Logigian; Janet E Sowden; Jorge L Almodovar; J Troy Littleton; Stephan Zuchner; Rita Horvath; Hanns Lochmüller
Journal:  Neurology       Date:  2015-10-30       Impact factor: 9.910

Review 3.  The association between Lambert-Eaton myasthenic syndrome and small cell lung carcinoma.

Authors:  Sarah Ew Briggs; Paul Gozzard; Denis C Talbot
Journal:  Immunotargets Ther       Date:  2013-05-21

Review 4.  Congenital Myasthenic Syndromes or Inherited Disorders of Neuromuscular Transmission: Recent Discoveries and Open Questions.

Authors:  Sophie Nicole; Yoshiteru Azuma; Stéphanie Bauché; Bruno Eymard; Hanns Lochmüller; Clarke Slater
Journal:  J Neuromuscul Dis       Date:  2017
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.